Saturday, October 19th, 2019
The Times Center242 W 41st Street, New York, NY 10036Register Now
We are inviting our community of scientists, physicians, patients, and interested members to submit their ideas for the 4th Annual Lyme Disease in the Era of Precision Medicine Conference on Saturday, October 19th, 2019.
If you are interested in leading a breakout session or have an idea for an interesting presentation topic or discussion area, please submit a short paragraph describing your thoughts (max 200 words) by July 31st, 2019.
To be included in our poster session, we ask professional members of the scientific and medical communities to submit a brief abstract (max 250 words) and presentation title due no later than July 31st, 2019.
You may be contacted sooner if we have any questions regarding your submission. For questions, please contact firstname.lastname@example.org
Its comprehensive focus: those who are dedicated to prevention, diagnostic and treatment innovations are exhibited alongside those who educate, perform research and advocate for patient care and support.
The fully immersive interview booth will highlight the individuals and stories faced in the battle with Lyme disease. We seek to represent the core of the human Lyme disease experience from the perspective of patient, clinician, caregiver, and researcher.
In addition to highlighting cutting edge research from scientists and clinicians, we’ve designed this year to provide patients with a greater sense of clarity on the advances the scientific community is making and how they can become more actively involved as citizen scientists.
We are an engaged community of clinicians, researchers, patients, advocates, and innovators. Our community of collaborators comes together annually to share in the mission of understanding, treating, and preventing this complex and devastating disease.
The Institute for Next Generation Healthcare is building a multiscale integrated network of Lyme Disease (LymeMIND) that will represent a unified, predictive model of Lyme disease.
LymeMIND will enable a systems medicine approach to identify novel biomarkers and new therapeutic opportunities. We are working with a network of collaborators to interrogate the complex biology of samples collected from Lyme-affected individuals using molecular profiling technologies and applying advanced statistical and machine learning approaches to move rapidly from “Big Data” to knowledge and improved understanding of the disease.
To learn more about the Institute for Next Generation Healthcare please visit nextgenhealthcare.org
© 2018 LymeMIND. All rights reserved.